Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Related Tags >> Vaccine Senator Ted Kennedy glioblastoma

chemotherapy News

Most Popular chemotherapy Story

New vaccine/chemo combo effective in cancer study

May 29, 2008 — 5:59am ET

New trial data shows that the combination of a chemotherapy drug and a new vaccine significantly prolonged the survival of patients with glioblastoma, the aggressive brain cancer that now afflicts Read more...

chemotherapy Press Releases

RedHill Biopharma is Preparing for an Advanced Clinical Trial with RHB-102, a Drug for the Prevention of Nausea and Vomiti
For the Treatment of Mutated EGFR Non-Small-Cell Lung Cancer, the Majority of Surveyed European Oncologists Indicate That
ImmunoCellular Therapeutics Receives Notice of Allowance of Key U.S. Patent for Lead Product Candidate
NORTHWEST BIO Announces Positive Third Quarter Progress
ImmunoCellular Therapeutics’ ICT-107 Recognized As One Of Windhover’s Top 10 Most Licensable Oncology Products

Latest Headlines

New vaccine/chemo combo effective in cancer study
May 29, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK